Empowering clinics to offer trusted post-procedure recovery care – and boost retail revenue.
One of Australia’s most trusted post-treatment recovery creams, Hirudoid, has officially launched a clinic-exclusive wholesale site, providing cosmetic clinics across the country with direct access to stock Hirudoid at wholesale prices — and offer patients high-quality recovery support at the point of care.
Used and recommended by pharmacists for over 50 years, Hirudoid is clinically proven to reduce the appearance of bruising, swelling, and inflammation following cosmetic procedures like injectables, threads, and laser treatments. Now, with the launch of the new platform, clinics can access the product conveniently and affordably, while also accessing attractive margins.
“Our goal is simple: improve recovery outcomes and enhance the patient experience,” said Phoebe Fuller, Product Manager at Hirudoid.
“Patients trust their practitioners, and having Hirudoid available immediately after treatment means they can start recovery with the right product — no extra pharmacy visit required.”
Key Benefits for Clinics and Patients:
- Exclusive wholesale pricing only available to registered cosmetic clinics
- Strong retail margins with the ability to double ROI through in-clinic sales
- Easy online ordering through a secure, user-friendly portal
- Product support assets including patient brochures and point of sale displays
A recent satisfaction survey* of cosmetic patients found that:
- 95% would use Hirudoid again post-treatment
- 89% noticed visible improvements in bruising and swelling within a few days
- Clinics that provided Hirudoid reported improved patient trust, satisfaction, and rebooking rates
This new initiative reinforces Hirudoid’s commitment to supporting both patients and the clinics they trust — by making clinical-grade aftercare more accessible, effective, and financially viable for businesses.
Cosmetic clinics can register for access at: Account – Hirudoid Australia
*Survey conducted with 40 Australian patients in Apr 2025, Toluna Immerse Report for Hirudoid
